1. Home
  2. INZY vs NECB Comparison

INZY vs NECB Comparison

Compare INZY & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • NECB
  • Stock Information
  • Founded
  • INZY 2015
  • NECB 1934
  • Country
  • INZY United States
  • NECB United States
  • Employees
  • INZY N/A
  • NECB N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • NECB Savings Institutions
  • Sector
  • INZY Health Care
  • NECB Finance
  • Exchange
  • INZY Nasdaq
  • NECB Nasdaq
  • Market Cap
  • INZY 255.3M
  • NECB 296.8M
  • IPO Year
  • INZY 2020
  • NECB N/A
  • Fundamental
  • Price
  • INZY $3.99
  • NECB $22.56
  • Analyst Decision
  • INZY Buy
  • NECB
  • Analyst Count
  • INZY 9
  • NECB 0
  • Target Price
  • INZY $15.22
  • NECB N/A
  • AVG Volume (30 Days)
  • INZY 1.3M
  • NECB 26.5K
  • Earning Date
  • INZY 08-05-2025
  • NECB 07-21-2025
  • Dividend Yield
  • INZY N/A
  • NECB 3.33%
  • EPS Growth
  • INZY N/A
  • NECB 0.72
  • EPS
  • INZY N/A
  • NECB 3.44
  • Revenue
  • INZY N/A
  • NECB $104,392,000.00
  • Revenue This Year
  • INZY N/A
  • NECB $2.80
  • Revenue Next Year
  • INZY N/A
  • NECB $8.34
  • P/E Ratio
  • INZY N/A
  • NECB $6.53
  • Revenue Growth
  • INZY N/A
  • NECB 2.77
  • 52 Week Low
  • INZY $0.72
  • NECB $16.69
  • 52 Week High
  • INZY $6.24
  • NECB $31.72
  • Technical
  • Relative Strength Index (RSI)
  • INZY 83.59
  • NECB 53.42
  • Support Level
  • INZY $3.94
  • NECB $21.82
  • Resistance Level
  • INZY $3.97
  • NECB $23.15
  • Average True Range (ATR)
  • INZY 0.01
  • NECB 0.51
  • MACD
  • INZY -0.10
  • NECB 0.01
  • Stochastic Oscillator
  • INZY 100.00
  • NECB 82.46

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

Share on Social Networks: